ArticleFrontiers in neurology2025

A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512.

Sergey Burd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.